从胚胎开始抓起，硅谷高管痴迷于打造“优秀”后代

Core Insights - There is a growing interest among Silicon Valley parents in using genetic testing services to screen embryos for traits such as intelligence, with costs reaching up to $50,000 [1][4] - Startups like Genomic Prediction and Nucleus Genomics are at the forefront of providing embryo genetic testing services, with Nucleus charging around $6,000 and Herasight up to $50,000 for their services [4][5] - The fertility tech sector has seen significant investment, with approximately $400 million raised annually from 2021 to 2023, attracting high-profile investors from the tech industry [5] Industry Trends - The demand for embryo genetic testing services is particularly high in the San Francisco Bay Area, driven by a demographic of ultra-high-net-worth individuals and rationalists obsessed with intelligence [1][4] - Companies like Herasight and Nucleus Genomics are expanding their offerings, with Herasight claiming to predict the likelihood of 17 different diseases and intelligence scores for embryos [4][5] Ethical and Legal Considerations - The practice of embryo genetic testing raises significant ethical and legal questions, including the reliability of the scoring methods and the transparency of the algorithms used [6][7] - While embryo screening for traits like intelligence is legal in the U.S., it faces strict prohibitions in countries like Germany, the UK, and Italy [7][8] - Concerns have been raised about the normalization of concepts like "superior" and "inferior" genes, potentially reinforcing societal inequalities based on biological factors [8]